SynthesisInternational journal of cancer2019

Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: A meta-analysis.

Lilan Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.